Neurologic oral manifestations caused by a new formulation of mirtazapineKLING, A; DAHLQVIST, R; JOHANSSON, S et al.Neurology. 2005, Vol 65, Num 2, pp 333-334, issn 0028-3878, 2 p.Article

Mirtazapine is effective in the prophylactic treatment of chronic tension-type headacheBENDTSEN, Lars; JENSEN, Rigmor.Neurology. 2004, Vol 62, Num 10, pp 1706-1711, issn 0028-3878, 6 p.Article

Placebo-controlled continuation treatment with mirtazapine: Acute pattern of response predicts relapseNIERENBERG, Andrew A; QUITKIN, Frederic M; KREMER, Charlotte et al.Neuropsychopharmacology (New York, NY). 2004, Vol 29, Num 5, pp 1012-1018, issn 0893-133X, 7 p.Article

More evidence on proneurocognitive effects of add-on mirtazapine in schizophreniaSTENBERG, Jan-Henry; TEREVNIKOV, Viatcheslav; JOFFE, Marina et al.Progress in neuro-psychopharmacology & biological psychiatry. 2011, Vol 35, Num 4, pp 1080-1086, issn 0278-5846, 7 p.Article

Population pharmacokinetic analysis of mirtazapineGRASMÄDER, Katja; VERWOHLT, Petra Louise; RAO, Marie Luise et al.European journal of clinical pharmacology. 2004, Vol 60, Num 7, pp 473-480, issn 0031-6970, 8 p.Article

Metabolism of the antidepressant mirtazapine in vitro : Contribution of cytochromes P-450 1A2, 2D6, and 3A4STÖRMER, Elke; VON MOLTKE, Lisa L; SHADER, Richard I et al.Drug metabolism and disposition. 2000, Vol 28, Num 10, pp 1168-1175, issn 0090-9556Article

Safety of mirtazapine in overdoseBREMNER, J. D; WINGARD, P; WALSHE, T. A et al.The Journal of clinical psychiatry. 1998, Vol 59, Num 5, pp 233-235, issn 0160-6689Article

Impact of the CYP2D6 ultrarapid metabolizer genotype on mirtazapine pharmacokinetics and adverse events in healthy volunteersKIRCHHEINER, Julia; HENCKEL, Hanns-Benjamin; MEINEKE, Ingolf et al.Journal of clinical psychopharmacology. 2004, Vol 24, Num 6, pp 647-652, issn 0271-0749, 6 p.Article

Capgras syndrome responding to the antidepressant mirtazapineKHOUZAM, Hani Raoul.Comprehensive therapy. 2002, Vol 28, Num 3, pp 238-240, issn 0098-8243, 3 p.Article

The use of mirtazapine in a patient with chronic painBRANNON, G. E; STONE, K. D.Journal of pain and symptom management. 1999, Vol 18, Num 5, pp 382-385, issn 0885-3924Conference Paper

Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatmentKIM, Sung-Wan; SHIN, Il-Seon; KIM, Jae-Min et al.Psychosomatics (Washington, DC). 2006, Vol 47, Num 5, pp 440-442, issn 0033-3182, 3 p.Article

De nouveaux antidépresseurs sur le marché = The new antidepressant agentSCHAAD, N.Médecine et hygiène. 2001, Vol 59, Num 2372, pp 2497-2500, issn 0025-6749Article

Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: A pilot studyHUNDLEY, Jennifer L; YOSIPOVITCH, Gil.Journal of the American Academy of Dermatology. 2004, Vol 50, Num 6, pp 889-891, issn 0190-9622, 3 p.Article

The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled studyZOCCALI, Rocco; MUSCATELLO, Maria Rosaria; CEDRO, Clemente et al.International clinical psychopharmacology. 2004, Vol 19, Num 2, pp 71-76, issn 0268-1315, 6 p.Article

A pilot study of mirtazapine in post-traumatic stress disorderCONNOR, K. M; DAVIDSON, J. R. T; WEISLER, R. H et al.International clinical psychopharmacology. 1999, Vol 14, Num 1, pp 29-31, issn 0268-1315Conference Paper

Delayed-Onset Mirtazapine-Related Leukopenia and RechallengeDHOLAKIA, Rashesh; SCHLEIFER, Steven J; AHMAD, Yasir J et al.Journal of clinical psychopharmacology. 2010, Vol 30, Num 6, issn 0271-0749, p. 758Article

Compulsive masturbation in infantile autism treated by mirtazapineALBERTINI, Giorgio; POLITO, Emilena; SARA, Marco et al.Pediatric neurology. 2006, Vol 34, Num 5, pp 417-418, issn 0887-8994, 2 p.Article

Psychiatrie = PsychiatryBERTSCHY, G; BRYOIS, C; FERRERO, F et al.Médecine et hygiène. 2000, Vol 58, Num 2284, pp 136-138, issn 0025-6749Article

Mirtazapine : Clinical advantages in the treatment of depressionBURROWS, G. D; KREMER, C. M. E.Journal of clinical psychopharmacology. 1997, Vol 17, Num 2, pp 34-39, issn 0271-0749, SUP1Conference Paper

Mirtazapine Decreases the Pain Feeling in Healthy ParticipantsARNOLD, Pierre; VUADENS, Philippe; KUNTZER, Thierry et al.The Clinical journal of pain. 2008, Vol 24, Num 2, pp 116-119, issn 0749-8047, 4 p.Article

Étude du comportement analytique de la mirtazapine en chromatographie liquide haute performance et électrophorèse capillaire de zone = Analytical behaviour of mirtazapine in high performance liquid chromatography and capillary zone electrophoresisLABAT, Laurence; DALLET, Philippe; DEVEAUX, Marc et al.Annales de toxicologie analytique. 2001, Vol 13, Num 2, pp 104-112, issn 0768-598XArticle

Biotransformation of mirtazapine by Cunninghamella elegansMOODY, Joanna D; FREEMAN, James P; FU, Peter P et al.Drug metabolism and disposition. 2002, Vol 30, Num 11, pp 1274-1279, issn 0090-9556, 6 p.Article

Unstimulated and glucose-stimulated ghrelin in depressed patients and controlsPASLAKIS, Georgios; WESTPHAL, Sabine; HAMANN, Bettina et al.Journal of psychopharmacology (Oxford). 2014, Vol 28, Num 6, pp 582-586, issn 0269-8811, 5 p.Article

Heart Rate Variability During Antidepressant Treatment With Venlafaxine and MirtazapineTERHARDT, Johannes; LEDERBOGEN, Florian; FEUERHACK, Anne et al.Clinical neuropharmacology. 2013, Vol 36, Num 6, pp 198-202, issn 0362-5664, 5 p.Article

Using conditioned place preference to identify relapse prevention medicationsNAPIER, T. Celeste; HERROLD, Amy A; DE WIT, Harriet et al.Neuroscience and biobehavioral reviews. 2013, Vol 37, Num 9, pp 2081-2086, issn 0149-7634, 6 p., aArticle